COVID-19: CDC, FDA and CMS Guidance

This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.

The Centers for Medicare & Medicaid Services released a toolkit for states to more quickly adopt Medicaid and Children's Health Insurance Program policies for telehealth's use during the COVID-19 pandemic.
The Centers for Disease Control and Prevention will award $631 million in Coronavirus Aid, Relief, and Economic Security Act funding to help public health agencies expand surveillance, testing and contact tracing to identify COVID-19 cases, protect vulnerable populations, and work with health care…
The Food and Drug Administration issued guidance allowing pharmacies and outsourcing facilities to repackage, under certain conditions and during the public health emergency, FDA-approved propofol drug products for hospitals having difficulty obtaining adequate supplies in the sizes they use to…
The Centers for Medicare & Medicaid Services unveiled a new COVID-19 toolkit for state and local health care decision makers seeking to maximize workforce flexibilities.
he Centers for Disease Control and Prevention updated its FAQs on COVID-19 laboratory testing and reporting. Topics include accessing laboratory testing, data and reporting, serology testing and ordering supplies.
Clinicians who participate in a clinical trial for a drug or biological product to treat a patient with novel coronavirus may now earn credit in the Merit-based Incentive Payment System, the Centers for Medicare & Medicaid Services announced.
The Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19.
The Food and Drug Administration said that it will temporarily forgo action against 503A compounding pharmacies that provide to hospitals certain compounded drugs without patient-specific prescriptions.
The Centers for Medicare & Medicaid Services April 21 and April 23 will host calls for hospitals, health systems and providers on COVID-19.